InBios Receives FDA EUA for Home Use Antigen Test for COVID-19

InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) allowing the company to market its SCoV-2 Ag Detect Rapid Self-Test, a three-step home use antigen test for COVID-19 that provides results in ~20 minutes.

(PRWeb November 30, 2021)

Read the full story at